Indian pharma company Lupin Limited has launched Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces, after getting an approval from the United States Food and Drug Administration (FDA).

Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces is a generic equivalent of Braintree Laboratories’ Suprep Bowel Prep Kit Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces.

Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution had estimated yearly sales of $202 million in the U.S. as per IQVIA MAT July 2022.

  FDA, Food and Drug Administration, Lupin, US, USFDA